MedTrace Logo

SBD121, a Synbiotic Medical Food for RA Management

NCT06005220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2025-12-18

No results posted yet for this study

Summary

The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and probiotic) will aid in the dietary management of symptoms of early rheumatoid arthritis (RA).

Conditions

Interventions

OTHER

SBD121

Medical Food

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Solarea Bio, Inc

    lead INDUSTRY

Principal Investigators

  • Maureen Stanley · Southern Star Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2025-10-06
Completion
2025-10-06

Countries

  • Australia
  • Bulgaria
  • Moldova
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06005220 on ClinicalTrials.gov